Theravance Biopharma Inc. (TBPH) Fundamentals

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
SHARE INFORMATION
Market Cap$ 723,001,728
Shares Outstanding76,427,244
Float49,671,973
Percent Float64.99%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 55,311,000
Latest Fiscal EPS$ -2.93
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions291
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months9,479,472
Institutional Holdings Percent107.5%
Institutional Sold Previous 3 Months12,641,324
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months20,000
Insider Holdings Percent8.5
Insider Sold Previous 3 Months21,618
Insider Shares Owned6,439,279
TRADING INFO
52 Week High$ 14.28
52 Week Low$ 6.10
52 Week High Change$ -27.51
21 Day Moving Average$ 9.0876
21 Day Extended Moving Average$ 9.1082
50 Day Moving Average$ 8.998
50 Day Extended Moving Average$ 9.1011
200 Day Moving Average$ 9.3385
200 Day Extended Moving Average$ 9.9243
10 Day Average Volume604,673
20 Day Average Volume829,643
30 Day Average Volume1,442,931
50 Day Average Volume1,048,502
Alpha-0.017393
Beta0.6849
Standard Deviation0.147570
R20.053888
7 Day Price Change$ -0.02
7 Day Percent Change-0.21%
21 Day Price Change$ -0.21
21 Day Percent Change-2.17%
30 Day Price Change$ 0.45
30 Day Percent Change4.99%
Month to Date Price Change$ 0.67
Month to Date Percent Change7.62%
Quarter to Date Price Change$ 0.40
Quarter to Date Percent Change4.42%
180 Day Price Change$ 0.25
180 Day Percent Change2.71%
200 Day Price Change$ 1.07
200 Day Percent Change12.75%
Year to Date Price Change$ -1.59
Year to Date Percent Change-14.39%

Theravance Biopharma Inc. (TBPH) Key Ratios

PROFITABILITY
EBIT Margin-103.4%
EBITDA Margin-86.8%
Pre-Tax Profit Margin-616.8%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 52,386,000
Revenue Per Share$ 0.6854
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-2.10
Total Debt To Equity0.00
Int Coverage-1.20
Current Ratio4.70
Leverage Ratio-1.10
Quick Ratio4.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-7.00
Enterprise Value$ 1,263,528,093
Price to Sales13.8014
Price to Free Cash-5.50
PE High Last 5 Years-5.10
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years-5.40
Price to Tangible Book-2.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.40
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-27.42
Return on Equity32.99
Return on Capital0.00

Theravance Biopharma Inc. (TBPH) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORick E. Winningham
Emplyoees159
Last AuditUQ
CIK0001583107
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressUgland House, South Church Street
George Town, PO Box 309
Grand Cayman, KY1-1104
Websitehttps://www.theravance.com
Facsimile-
Telephone+1 650 808-6000
Emailinvestor.relations@theravance.com


Your Recent History
NASDAQ
TBPH
Theravance..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.